Fundz

InterVene, Inc. raised $13M in a Series A led by Treo Ventures and RiverVest Venture Partners to advance the Recana™ system through US market clearance.

PRIVATEOct 07, 2024

Amount Raised

$13 Million

Round Type

Series A

South San FranciscoHealthcare

Investors

Treo VenturesRivervest Venture Partners

Description

InterVene, Inc. announced the closing of its $13M Series A financing round co-led by Treo Ventures and RiverVest Venture Partners. The proceeds will fund the final development of its Recana catheter system and support preparation for initial commercialization.

Quick answer

InterVene raised $13 Million in a Series A round, dated October 7, 2024. Investors: Treo Ventures and Rivervest Venture Partners. InterVene is based in South San Francisco, California, United States.

How much did InterVene raise?
InterVene raised $13 Million in a Series A round on October 7, 2024.
Who invested in InterVene?
Treo Ventures and Rivervest Venture Partners are named as investors in this round.
What does InterVene do?
InterVene is a medical device start-up company reinventing the way physicians treat severe venous disease in the legs.
Where is InterVene based and how big is it?
InterVene is based in South San Francisco, California, United States.
Who are the decision-makers at InterVene?
Fundz holds 1 contact at InterVene. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare around the same time

Companies in the same sectors as InterVene that raised within 45 days of this round, from Fundz verified event records.

  • Somatix raised $1.3M on November 21, 2024.
  • Biofrontera raised $4.2M (Seed) on November 21, 2024.
  • Ria Health raised $6M on November 21, 2024.
  • Tocagen Inc raised $53M (Post-IPO Equity) on November 20, 2024.
  • Aclaris Therapeutics raised $80M on November 19, 2024.
  • TruLite Health raised $2.9M (Series A) on November 19, 2024.

Who to call at InterVene, and when

A new round usually means InterVene is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day InterVene raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at InterVene, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at InterVene. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

InterVene

Location

South San Francisco, California, United States

About

InterVene is a medical device start-up company reinventing the way physicians treat severe venous disease in the legs. InterVene's BlueLeaf(TM) Endovenous Valve Formation System represents the first ever non-implantable, endovenous approach to deep vein valve failure. This technology allows physicians to create new vein valves for patients who are unable to efficiently pump blood out of their legs and back to their heart. Millions of Americans currently suffer from painful venous stasis ulcers (VSU’s) and other costly and devastating symptoms, yet no minimally invasive therapy exists to treat deep vein valve failure, one of the most prevalent underlying causes of these symptoms. InterVene plans to change that.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment InterVene raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts5 people are listed at InterVene. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for InterVene's next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

InterVene raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.